Clinical Trial Update: The Value of 68Ga-grazytracer PET in Monitoring Responses to Immunotherapy of Gastrointestinal Malignancies

View source ↗

Summary

A clinical trial is evaluating the use of the PET tracer 68Ga-grazytracer to monitor responses to immunotherapy in patients with gastrointestinal malignancies. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastrointestinal Malignancies

Drugs mentioned

• 68Ga-grazytracer

Snippet

Sponsor: Ruijin Hospital | Conditions: Gastrointestinal Malignancies | Status: RECRUITING